Inselspital University Hospital Bern
Bern, 3010, Switzerland
Location status: Recruiting
NCT Number: NCT07434726
This study will test if a sustained Return of Spontaneous Circulation (ROSC) in patients with cardiac arrest is more frequent when patients receive advanced cardiac life support (ACLS) alone or when they receive ACLS plus a balloon occlusion of the thoracic aorta.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Bern, 3010, Switzerland
Location status: Recruiting
Patients with in-hospital cardiac arrest (IHCA) outside the operating room, the coronary angiography suite and the intensive care unit (ICU) will be attended to by the hospitals resuscitation team and provided with advanced cardiac life support (ACLS) as per usual practice.
A research team will be deployed simultaneously and, when patients meet inclusion criteria, will randomize patients to ACLS alone or to ACLS plus balloon occlusion of the descending thoracic aorta by means of a resuscitative endovascular occlusion of the aorta (REBOA) catheter.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Insertion of a balloon catheter through the common femoral artery, retrograde advancement of the catheter into the descending thoracic aorta, ballon occlusion of the aorta
Advanced Cardiac Life Support (ACLS) as per American Heart Association (AHA) or European Resuscitation Council (ERC) standards
Time frame: Up to 1 hour after study inclusion
Any return of spontaneous circulation lasting longer then 20 minutes
Time frame: at hospital discharge, up to 90 days after study inclusion
dead or alive
Time frame: 6 month after study inclusion
dead or alive
Time frame: Day 30 after study inclusion
measured by means of modified ranking scale
Time frame: 6 month after study inclusion
measured by means of modified ranking scale
Time frame: at hospital discharge, up to 90 days after study inclusion
Time frame: 30 days after study inclusion
Time frame: Continuously assessed during ongoing resuscitation, up to 1 hour after study inclusion
Exploratory, measured in %
Time frame: at six month
exploratory, written description
Time frame: at inclusion, 30 minutes after inclusion and once up to day 3
exploratory
Time frame: at inclusion, 30 minutes after inclusion and once up to day 3
exploratory
Contact information is provided by the study sponsor or research team.
Cornelia Lammbrigger, RN
CONTACT
Wolf E Hautz, MD, MME
CONTACT
Insel Gruppe AG, University Hospital Bern
Other
CPReboa: In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta
Acronym: CPReboa
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06672159
Arrhythmias, Cardiac, Cardiac Arrest
Trondheim, Norway
View Trial DetailsNCT05890716
Arrhythmias, Cardiac, Cardiac Arrest
Groningen, Provincie Groningen, Netherlands
View Trial DetailsNCT07707037
Anxiety Depression, Cardiac Arrest
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06617377
Cardiac Arrest, Cardiovascular Diseases
Toulouse, France
View Trial Details